Bruce Follows

This inventor holds 29 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Ubiquitin-Protein Inhibitors. Top assignees: Forma Therapeutics, Inc., Valo Early Discovery, Inc., Valo Health, Inc.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce Follows. Retrieved from https://idiyas.com/inventor/bruce-follows

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 6)

% Patents Active = 96.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 7.5

ph-index = 10

Forward Citations = 262(Granted Patents)

Company Filing History:

20 out of 125

Forma Therapeutics, Inc.

patents

5 out of 15

Valo Early Discovery, Inc.

Years Active: 2009-2024

Loading Chart...

Areas of Expertise:

Ubiquitin-Specific Protease 1

Ubiquitin-Specific Protease 7

Purinones

Quinazolinones

Pyrrolotriazinones

Thienopyrimidinones

Isothiazolopyrimidinones

Pyrrolo

Pyrazolopyrimidines

Protein Tyrosine Phosphatase

Inhibitors

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors (2024-07-23),

2. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2024-06-25),

3. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors (2023-10-24),

4. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2023-08-29),

5. 11161848 - Purinones as ubiquitin-specific protease 1 inhibitors (2021-11-02),

6. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors (2021-04-20),

7. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2021-03-02),

8. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors (2021-02-23),

9. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors (2021-02-02),

10. 10836741 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2020-11-17),

11. 10519130 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2019-12-31),

12. 10519129 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2019-12-31),

13. 10519128 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2019-12-31),

14. 10519127 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2019-12-31),

15. 10513508 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors (2019-12-24),

Title: Inventor Bruce Follows

Introduction: Bruce Follows is a renowned inventor based in Littleton, MA (US) known for his groundbreaking contributions to various industries.

Latest Patents: Bruce Follows holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: Throughout his career, Bruce Follows has been recognized for his ability to transform creative ideas into practical solutions, earning him a reputation as a visionary inventor.

Collaborations: Bruce Follows has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his commitment to driving innovation through partnerships.

Conclusion: Bruce Follows continues to inspire the next generation of inventors with his passion for pushing the boundaries of what is possible through his inventive spirit and dedication to creating a better future.

Profile summary based on public USPTO records.